Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Chatelain

Showing results (71-80 of 306) with videos related to

Pageof 31
Sort By:
Journal of Cardiovascular Pharmacology|September 1, 1995
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized ratsA S Manning, C Bruyninckx, J Ramboux, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 18, 2008
Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurementsP Chatelain, R Crabbé, H Saunders, et al.
Biochemical and Biophysical Research Communications|August 28, 1979
Specific interaction between follitropin and GM1 ganglioside incorporated into lipid membranesM Deleers, P Chatelain, A Poss, et al.
Biochemical Pharmacology|September 15, 1986
Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization studyP Chatelain, J Ferreira, R Laruel, et al.
Journal of Endocrinological Investigation|May 14, 2008
Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growthR Crabbé, M von Holtey, P Engrand, et al.
Cancer Research|December 1, 1992
Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizineJ P Jaffrézou, T Levade, P Chatelain, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1984
Antihypertensive activity of tibalosine (CP 804 S) in the rat. Possible involvement of a central alpha 1-adrenergic receptor blockadeP Chatelain, M Claeys, W van Dorsser, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 23, 2009
[How hypospadias should be investigated?]C Bouvattier, C-L Gay, P Bougnères, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 1, 1996
[Growth factors, fetal development and fetal growth deficiency]P Chatelain, O Claris, A Lapillonne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1986
Serum bone GLA-protein in growth hormone deficient childrenP D Delmas, P Chatelain, L Malaval, et al.
Pageof 31

Showing results (71-80 of 306) with videos related to

Sort By:
Pageof 31
Journal of Cardiovascular Pharmacology|September 1, 1995
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized ratsA S Manning, C Bruyninckx, J Ramboux, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|June 18, 2008
Changes in insulin sensitivity and glucose metabolism during therapy with recombinant human growth hormone in short children born small for gestational age show a negative correlation with baseline measurementsP Chatelain, R Crabbé, H Saunders, et al.
Biochemical and Biophysical Research Communications|August 28, 1979
Specific interaction between follitropin and GM1 ganglioside incorporated into lipid membranesM Deleers, P Chatelain, A Poss, et al.
Biochemical Pharmacology|September 15, 1986
Amiodarone induced modifications of the phospholipid physical state. A fluorescence polarization studyP Chatelain, J Ferreira, R Laruel, et al.
Journal of Endocrinological Investigation|May 14, 2008
Recombinant human growth hormone for children born small for gestational age: meta-analysis confirms the consistent dose-effect relationship on catch-up growthR Crabbé, M von Holtey, P Engrand, et al.
Cancer Research|December 1, 1992
Modulation of subcellular distribution of doxorubicin in multidrug-resistant P388/ADR mouse leukemia cells by the chemosensitizer ((2-isopropyl-1-(4-[3-N-methyl-N-(3,4-dimethoxy-beta- phenethyl)amino]propyloxy)-benzenesulfonyl))indolizineJ P Jaffrézou, T Levade, P Chatelain, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|April 1, 1984
Antihypertensive activity of tibalosine (CP 804 S) in the rat. Possible involvement of a central alpha 1-adrenergic receptor blockadeP Chatelain, M Claeys, W van Dorsser, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|June 23, 2009
[How hypospadias should be investigated?]C Bouvattier, C-L Gay, P Bougnères, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 1, 1996
[Growth factors, fetal development and fetal growth deficiency]P Chatelain, O Claris, A Lapillonne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|August 1, 1986
Serum bone GLA-protein in growth hormone deficient childrenP D Delmas, P Chatelain, L Malaval, et al.
Pageof 31